SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation that cannabis rescheduling could be on the horizon following reports of potential executive action. The community is actively discussing the implications of this policy change, particularly how it might trigger a short squeeze and impact the broader cannabis sector. Some are also pointing to Tilray's 'Liquid Diamond' vapes as a potential catalyst.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending after its earnings report triggered a volatile swing, initially rising on strong AI chip sales and guidance, but then sharply declining during the earnings call. Community discussion revolves around potential profit-taking, concerns about non-AI revenue, and the impact of comments made during the call. Despite strong fundamentals, the stock's reaction highlights the market's sensitivity to AI-related news and broader sector trends.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as the community rallies around its cultural significance within the cannabis space and its positioning as a "culture coin" on the Solana network. Discussions also highlight potential synergies with broader cannabis reform and related stocks like $TLRY, with community members emphasizing the project's long-term vision.

Aventus Network

Aventus Network ($AVT) is trending as traders discuss a potential breakout, Polkadot integration, and recent strategic advisory appointment in the UAE. Bullish traders are highlighting its oversold conditions and low market cap as catalysts for a potential rally. Community members are closely monitoring volume and potential new exchange listings.

Yee is a community based memecoin with one mission: to fight Pepe again. Made to honor the iconic meme rivalry we all know and love.  The Yee Legend  [Filed by: Yee’s Archivist & Legal Representative]  There’s something the meme world refuses to talk about: Pepe the Frog stole Yee the Dino’s entire launch plan.  Yee had been preparing for his comeback for months, but Pepe launched two weeks earlier, hijacking Yee’s concept and selling it as his own.  The charges? Meme theft, intellectual forgery, and historical erasure.  Yee’s official contract was filed in April 2023, right after Pepe’s surprise drop. This wasn’t timing—it was theft. The archives are about to open, and history is about to be corrected

Yee Token

Yee Token ($YEE) is trending amid growing community enthusiasm and strong bullish sentiment, with some drawing comparisons to previous meme coin successes. The community is rallying behind $YEE's potential as an ERC-20 token on Ethereum, emphasizing its momentum and strong fundamentals. Some community members believe $YEE could become a leading narrative in the crypto space.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amidst a potential bidding war with Paramount for Warner Bros. Discovery, with some investors hoping Netflix will abandon the deal and collect a $2.8 billion breakup fee, potentially boosting the stock; community chatter revolves around the deal's implications, regulatory hurdles, and potential impact on Netflix's financials and content strategy.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UNH is trending as investors weigh its potential amid healthcare sector rotation and anticipation of a dividend payout. Technical analysts point to a possible breakout above the $340 resistance, while some community members speculate on news regarding ACA subsidies and potential DOJ developments as catalysts for a significant move. Despite some bearish sentiment, many see UNH as a long-term hold due to its leadership in the healthcare industry.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is trending as investors digest better-than-expected earnings and revenue, alongside news of the CEO's upcoming departure which some see as a potential catalyst for innovation. Community discussions revolve around the company's guidance, share buybacks, and the potential for analyst upgrades. Bullish sentiment seems to be building on the prospect of new leadership and continued growth, particularly in the international market.

Costco Wholesale Corp. engages in the provision of operation of membership warehouses through wholly owned subsidiaries. It operates through the following geographical segments: United States, Canada, and Other International Operations. The company was founded by James D. Sinegal and Jeffrey H. Brotman in 1983 and is headquartered in Issaquah, WA.

Costco Wholesale Corp

Costco is trending amid discussions around its recent earnings, where the company beat EPS estimates but missed on revenue, leading to mixed reactions from investors. Community members are debating whether the stock's high PE ratio is justified, while others are focused on membership growth and digital sales. Some are speculating about a potential special dividend or stock split to attract more investors.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk ($NVO) is trending amid discussions around potential FDA approval for its oral weight loss pill, Wegovy, with some anticipating an imminent announcement. The community is analyzing competitor Eli Lilly's ($LLY) success and side effects from its weight loss drugs, speculating on how Novo Nordisk's treatments, especially CagriSema, will fare in the competitive landscape. Additionally, news of a bill targeting compounded GLP-1 drugs is seen as a potential positive catalyst for NVO.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Astria Therapeutics, Inc. $ATXS Shares Acquired by JPMorgan Chase & Co.

JPMorgan Chase & Co. boosted its position in Astria Therapeutics, Inc. (NASDAQ:ATXS - Free Report) by 4,607.1% during the second quarter, according to its most recent 13F filing with the Securities...

Panagora Asset Management Inc. Purchases New Holdings in Astria Therapeutics, Inc. $ATXS

Panagora Asset Management Inc. acquired a new position in Astria Therapeutics, Inc. (NASDAQ:ATXS - Free Report) during the 2nd quarter, according to the company in its most recent Form 13F filing...

Astria Therapeutics (NASDAQ:ATXS) Sees Large Volume Increase - What's Next?

Astria Therapeutics (NASDAQ:ATXS) Sees Large Volume Increase - Here's What Happened...

Astria Therapeutics, Inc. (NASDAQ:ATXS) Receives Average Rating of "Hold" from Analysts

Shares of Astria Therapeutics, Inc. (NASDAQ:ATXS - Get Free Report) have been given an average recommendation of "Hold" by the eleven analysts that are currently covering the firm, MarketBeat...

Halper Sadeh LLC Encourages RNA, TCBX, ATXS, FSUN Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC Encourages RNA, TCBX, ATXS, FSUN Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages RNA, TCBX, ATXS, FSUN Shareholders to Contact the Firm to...

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--TCBX, RNA, ATXS, and FSUN

$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--TCBX, RNA, ATXS, and FSUN $HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--TCBX...

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-SPNS, PCH, ATXS, and RYN

$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-SPNS, PCH, ATXS, and RYN $HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Mergers-SPNS, PCH...

Bailard Inc. Buys New Shares in Astria Therapeutics, Inc. $ATXS

Bailard Inc. acquired a new position in Astria Therapeutics, Inc. (NASDAQ:ATXS - Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange...

Astria Therapeutics (NASDAQ:ATXS) Posts Quarterly Earnings Results, Misses Estimates By $0.13 EPS

Astria Therapeutics (NASDAQ:ATXS - Get Free Report) issued its earnings results on Wednesday. The biotechnology company reported ($0.55) earnings per share (EPS) for the quarter, missing the...

Astria Therapeutics (NASDAQ:ATXS) Lowered to "Neutral" Rating by Cantor Fitzgerald

Cantor Fitzgerald lowered Astria Therapeutics from an "overweight" rating to a "neutral" rating in a research note on Wednesday...

Astria Therapeutics, Inc. engages in the discovery, development, and commercialization of novel therapeutics. Its lead product candidate is STAR-0215, which is intended to treat Hereditary Angioedema, a rare genetic disorder characterized by severe, recurrent, unpredictable, painful, and sometimes life-threatening swelling in the face, limbs, abdomen, and airway. The company was founded by Michael R. Jirousek, Jill C. Milne and Steven E. Shoelson on June 26, 2008 and is headquartered in Boston, MA.

Astria Therapeutics Inc

Bullish: S&P grinds higher

Choppy but up: buy dips

Sideways: fade the move

Bearish: this rally falls off

The Federal Reserve just announced a 0.25 percentage point interest rate cut at its December 10, 2025 meeting.​ Share your outlook on how the latest Federal Reserve interest rate cut will impact stocks and the S&P 500 over the next month.

How do you think today’s Fed rate cut impacts stocks over the next month?

Current Price	$12.91
Prev Close	$12.97
Open	$13.01
Dividend Yield	0.00%
50-Day Moving Average	$11.78
Beta	1.15
Avg. Volume	1.06M
PE Ratio	-6.00

52-Week High	$13.29
52-Week Low	$3.56
Market Capitalization	$740.39M
EPS (Annual)	-$1.68
Price to Book	5.28
Revenue Per Employee	$0.00
Enterprise Value/EBITDA	N/A

ATXS
Astria Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ATXS News

ATXSAstria Therapeutics Inc